QA: Balchem CORP in us_medicinal_products/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000009326_2024_Balchem_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000009326, Balchem CORP

  xvar xval
0 LiabilitiesNoncurrent 14,601,000
1 LiabilitiesCurrent 200,537,000
2 remainder_Liabilities 328,089,000
3 AssetsCurrent 314,242,000
4 AssetsNoncurrent 34,710,000
5 PropertyPlantAndEquipmentNet 276,039,000
6 Goodwill 970,119,000
7 remainder_Assets 2,101,000
8 GeneralAndAdministrativeExpense 748,197,000
9 ResearchAndDevelopmentExpense 15,049,000
10 remainder_Expenses 28,718,000
11 remainder_Revenues 922,439,000
12 remainder_NetIncome -21,932,000
13 remainder_ComprehensiveNetIncome 15,845,000
  yvar yval
0 Liabilities 543,227,000
1 Assets 1,597,211,000
2 Expenses 791,964,000
3 Revenues 922,439,000
4 StockholdersEquity 1,053,984,000
5 NetIncome 108,543,000
6 ComprehensiveNetIncome 116,465,500
7 BaseVar 1,946,309,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.46
9 EconomicCapitalRatio 1.99

Edgar->Model Mapping

Feature Distribution

Change over Time